Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Title:

Abbravation: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Abbravation:

Publisher

Kluwer Academic Publishers-Plenum Publishers

Search In Publisher:

DOI

10.1016/0960-894x(94)00470-z

Search In DOI:

ISSN

0090-466X

Search In ISSN:
Search In Title Of Papers:

Quinidine pharmacokinetics in man Choice of a dis

Authors: Theodor W Guentert Nicholas H G Holford Peter E Coafes Robert A Upton Sidney Riegelman
Publish Date: 2015/07/17
Volume: 7, Issue: 4, Pages: 315-330
PDF Link

Abstract

Parameters describing disposition and absolute oral bioavailability of quinidine were determined in ten normal male volunteers using a specific assay Various models were compared for their ability to describe the experimental data An intravenous quinidine gluconate and an oral quinidine sulfate solution were administered 374 mg/kg quinidine base In three subjects the intravenous and oral studies were repeated One two and threecompartment models with zeroand firstorder input were fitted to the plasma concentrations The selection of the best model was made by the Akaike information criterion and by eye After intravenous administration plasma concentrationtime curves could be adequately described by a twocompartment model Mean disposition constants ±SD were obtained from individualized fits V1 0398 ±0336 liter/kg Vdarea 253±072 liter/kg α 0316±0294 min−1 Β 000204 ± 000262 min1 k2 00305 ±0010 min−1 A clearance of 49 ±15 ml/min/kg was observed After oral administration threecompartment models were needed to describe the observed data in some cases Absorption was in most cases best described by a zeroorder rather than by a firstorder process The time to peak concentration varied from 23 to 121 min the lag time was always less than 3 min and the mean elimination rate constant was 000171 min−1 The mean oral bioavailability of quinidine was 070 ±017This study was supported by funds from Food and Drug Administration Contract No 223743145 T W G acknowledges support from the Swiss National Science Foundation N H G H received a NIH fellowship for training in Clinical Pharmacology GM 00001


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Influence of plasma protein binding kinetics on hepatic clearance assessed from a “tube” model and a “well-stirred” model
  2. Effect of plasma protein and tissue binding on the time course of drug concentration in plasma
  3. A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients
  4. Linear pharmacokinetic models: Geometric construction to determine transfer and elimination rate constants
  5. Modeling of drug response in individual subjects
  6. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model
  7. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man
  8. Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans
  9. Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: Effect of model misspecification
  10. Estimation of drug binding parameters
  11. Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing
  12. Pharmacokinetics of teicoplanin in man after intravenous administration
  13. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics
  14. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  15. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  16. Simulation for population analysis of Michaelis-Menten elimination kinetics
  17. Pharmacodynamic modeling of the in vitro vasodilating effects of organic mononitrates

Search Result: